Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)

SHA:600381 Revenue

Qinghai Spring Medicinal Resources Technology had revenue of 87.66M CNY in the quarter ending September 30, 2025, with 46.94% growth. This brings the company's revenue in the last twelve months to 284.76M, up 13.36% year-over-year. In the year 2024, Qinghai Spring Medicinal Resources Technology had annual revenue of 270.26M with 26.36% growth.

• Revenue (ttm): 284.76M
• Revenue Growth: +13.36%
• P/S Ratio: 6.07
• Revenue / Employee: 1.79M
• Employees: 159
• Market Cap: 1.73B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	270.26M	56.39M	26.36%
Dec 31, 2023	213.88M	53.70M	33.52%
Dec 31, 2022	160.18M	32.41M	25.37%
Dec 31, 2021	127.76M	3.50M	2.81%
Dec 31, 2020	124.27M	-109.48M	-46.84%